Ado-trastuzumab emtansine（chemical name: T-DM1）is a combination of trastuzumab and the chemotherapy medicine emtansine,Doctors call Kadcyla an ADC（antibody-drug conjugate）targeted therapy.
This medication is used to treat tumors that produce more than the normal amount of a certain substance called HER2 protein.
- HER2-positive metastatic breast cancer that has previously been treated with Herceptin (chemical name: trastuzumab) and taxane chemotherapy
- early-stage HER2-positive breast cancer after surgery if residual disease was found after neoadjuvant (before surgery) treatment with Herceptin and taxane chemotherapy
Ado-trastuzumab emtansine sold as brand names Kadcyla ,and It has a generic form of several brands.
Brand Name : Ujvira
Composition : Ado-Trastuzumab Emtansine
Indication：Antineoplastic－Antibody-Drug Conjugates (ADCs) · Antineoplastic-HER2 Targeted Antibody-Microtubule Inhibitor Conjugate
Form : injection（lyophilized powder for reconstitution）
Packing 1: 100mg/vial in 1 bottle
Packing 2: 160mg/vial in 1 bottle
Manufactured By：Zydus Ingenia[India]
Storage : Unused vials: Refrigerate at 2-8ºC (36-46°F)
Reconstituted vials or diluted solutions : Refrigerate at 2-8ºC (36-46°F)/Discard after 24 hr/Do NOT freeze